Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early plerixafor use in healthy stem cell donors
ISRCTN73055142Phase 2Recruiting
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Nov 2026
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of plerixafor (3 cohorts), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: One-day collection success after G-CSF + plerixafor. Started Nov 2026; status: recruiting.
02
Drugs
plerixafor
Beyond the preview
Go deeper on ISRCTN73055142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73055142.